Drugs / Bushen Tongzhi Formula
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07347340 | Jan 2026 → Jan 2028 expected | ovarian dysfunction | Peking Union Medical College Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bushen Tongzhi Formula | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07347340 ↗ |
| Known as | Xiehe DOR Bushen Tongzhi Formula | “the "Bushen Tongzhi Formula" (also referred to as the "Xiehe DOR Bushen Tongzhi Formula"), as a pretreatment and adjuvant therapy” NCT07347340 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a traditional Chinese herbal pretreatment” NCT07347340 ↗ |
| Route | Oral | “taken orally three times daily after meals.” NCT07347340 ↗ |